PCM
ABBV icon

Peak Capital Management’s AbbVie ABBV Stock Holding History

Peak Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,668
Closed -$988K – 63
2018
Q2 		$988K Buy
+10,668
New +$1.04M 0.6% 38
2018
Q1 		– Sell
-12,084
Closed -$1.07M – 68
2017
Q4 		$1.07M Sell
12,084
-101
-0.8% -$9.52K 0.73% 31
2017
Q3 		$1.08M Sell
12,185
-3,389
-22% -$258K 0.72% 31
2017
Q2 		$1.13M Buy
+15,574
New +$1.05M 0.63% 38

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Peak Capital Management's ABBV Position: Q3 2018 in Review

Peak Capital Management sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 10,668 shares — an estimated $988K sold.

Peak Capital Management first reported a position in ABBV in Q2 2017 and held it in 4 quarters. The position peaked at $1.13M in Q2 2017. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Peak Capital Management reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Peak Capital Management sold 10,668 AbbVie shares in Q3 2018, an estimated $988K.
  • Peak Capital Management first reported a position in AbbVie in Q2 2017 and held it in 4 quarters.
  • Peak Capital Management's AbbVie position peaked at $1.13M in Q2 2017.
  • 1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Peak Capital Management's 13F filing for Q3 2018, filed 20 Nov 2018.